Today's Highlights
Premium
Good News and Bad News Unrelated to Prohost Picks. See Also: AMGN, JAZZ, ACHN and CYTX
GOOD NEWS AMGEN (AMGN) said its experimental drug AMG 416 aimed at treating hyperparathyroidism, or excessive secretion of parathyroid hormone, in kidney disease patients on dialysis has met its endpo...
P
Prohost Biotech
1 min read
16
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Tags
Comments (0)
Please sign in to join the discussion